CYRX:NSD-Cryoport Inc (USD)

COMMON STOCK | Integrated Freight & Logistics |

Last Closing

USD 8.08

Change

+0.21 (+2.67)%

Market Cap

USD 0.36B

Volume

0.19M

Analyst Target

USD 23.63
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Integrated Freight & Logistics

Symbol Name Price(Change) Market Cap
JBHT JB Hunt Transport Services Inc

+0.44 (+0.26%)

USD 18.25B
EXPD Expeditors International of Wa..

+0.08 (+0.07%)

USD 16.70B
CHRW CH Robinson Worldwide Inc

+0.04 (+0.04%)

USD 13.17B
LSTR Landstar System Inc

-1.35 (-0.77%)

USD 6.59B
HUBG Hub Group Inc

+0.39 (+0.89%)

USD 3.02B
FWRD Forward Air Corporation

+2.28 (+8.03%)

USD 0.96B
BTOC Armlogi Holding Corp. Common S..

+0.07 (+1.57%)

USD 0.17B
CRGO Freightos Limited Ordinary sha..

-0.02 (-0.69%)

USD 0.12B
SFWL Shengfeng Development Limited ..

-0.01 (-0.95%)

USD 0.10B
STCN Steel Connect Inc

-0.06 (-0.48%)

USD 0.08B

ETFs Containing CYRX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Integrated Freight & Logistics) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -47.84% 46% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.84% 46% F 18% F
Trailing 12 Months  
Capital Gain -49.41% 46% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.41% 46% F 18% F
Trailing 5 Years  
Capital Gain -50.22% 33% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.22% 33% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain 26.55% 92% A 78% C+
Dividend Return 26.55% 92% A 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 155.77% 23% F 15% F
Risk Adjusted Return 17.04% 69% C- 49% F
Market Capitalization 0.36B 63% D 56% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector